The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib. Basel biotech Rhizen has discovered…

Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed will use this financing to…

The US firm Axtria has established a new office in Basel. The company offers services for the life sciences industry…

The Technologiepark Basel will be ten years old in 2021. Over the past decade, it has supported many startups and…

The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital Report. Last year, more than…

Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to…

Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft in order to benefit from…

The biotech company Evolva is introducing L-arabinose to the market. This product is a natural sugar blocker and can be…

Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest subsidiary in Basel. With Zifo…